Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.16% |
| 2 | Financials | 5.29% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
5826
Ellington Financial
EFC
$1.69B
| $67K | ﹤0.01% |
3,727
-6,121
| -62% | -$109K |
|
5827
EVI Industries
EVI
$195M
| $67K | ﹤0.01% |
2,110
-795
| -27% | -$26.4K |
|
5828
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$70.3M
| $67K | ﹤0.01% |
+13
| New | +$53.5K |
|
5829
Arcus Biosciences
RCUS
$3.33B
| $67K | ﹤0.01% |
7,354
-3,689
| -33% | -$29.6K |
|
5830
BRC Group Holdings
RILY
$264M
| $67K | ﹤0.01% |
2,821
-2,328
| -45% | -$49.3K |
|
|
VSI
5831
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
| $67K | ﹤0.01% |
10,200
+6,400
| +168% | +$36K |
|
|
CVRS
5832
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $67K | ﹤0.01% |
15,646
-20,079
| -56% | -$72.9K |
|
5833
PUT
Franklin Resources
BEN
$16.8B
| $66K | ﹤0.01% |
2,300
-4,200
| -65% | -$128K |
|
5834
Consolidated Water Co
CWCO
$472M
| $66K | ﹤0.01% |
4,022
-1,662
| -29% | -$24.4K |
|
5835
VanEck Emerging Markets High Yield Bond ETF
HYEM
$522M
| $66K | ﹤0.01% |
2,835
+400
| +16% | +$9.37K |
|
5836
PUT
Louisiana-Pacific
LPX
$5.14B
| $66K | ﹤0.01% |
2,700
-3,200
| -54% | -$78.8K |
|
5837
CALL
Novavax
NVAX
$1.21B
| $66K | ﹤0.01% |
13,080
-1,915
| -13% | -$10.5K |
|
5838
Petrobras Class A
PBR.A
$106B
| $66K | ﹤0.01% |
5,040
-3,830
| -43% | -$51.1K |
|
5839
Invesco Global Water ETF
PIO
$271M
| $66K | ﹤0.01% |
2,346
+202
| +9% | +$5.61K |
|
5840
PUT
SM Energy
SM
$7.6B
| $66K | ﹤0.01% |
6,800
+500
| +8% | +$5.1K |
|
|
ALTA
5841
DELISTED
Altabancorp
ALTA
| $66K | ﹤0.01% |
2,331
-1,904
| -45% | -$54.1K |
|
5842
Civeo
CVEO
$356M
| $65K | ﹤0.01% |
4,262
-25
| -0.6% | -$441 |
|
5843
Franklin Covey
FC
$239M
| $65K | ﹤0.01% |
1,860
-1,383
| -43% | -$49.9K |
|
|
FLC
5844
Flaherty & Crumrine Total Return Fund
FLC
$173M
| $65K | ﹤0.01% |
2,885
+2,874
| +26,127% | +$61.3K |
|
5845
Qfin Holdings
QFIN
$1.68B
| $65K | ﹤0.01% |
7,304
-3,986,414
| -100% | -$41.2M |
|
5846
Verra Mobility
VRRM
$775M
| $65K | ﹤0.01% |
4,534
-23,014
| -84% | -$320K |
|
|
CATC
5847
DELISTED
CAMBRIDGE BANCORP
CATC
| $65K | ﹤0.01% |
873
-597
| -41% | -$46.1K |
|
|
JTD
5848
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
| $65K | ﹤0.01% |
3,883
-6,069
| -61% | -$101K |
|
|
EIDX
5849
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $65K | ﹤0.01% |
1,810
-2,626
| -59% | -$103K |
|
5850
Abeona Therapeutics
ABEO
$355M
| $64K | ﹤0.01% |
1,137
-982
| -46% | -$73.5K |
|
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 268 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.